arrow
返回
J

Jeffrey E. Lancet

Lee Moffitt Cancer Center and Research Institute

62H指数
881论文数
1.5W被引数
收录论文 94
发表时间
American Society of Hematology 2026 guidelines for treating newly diagnosed acute myeloid leukemia in older adultsSekeres, M.A.; Mattison, R.J.; Artz, A.S.; Baer, M.R.; Chua, C.C.; Demichelis-Gomez, R.; Egan, P.C.; Fletcher, L.; Foucar, C.E.; Garcia, J.S.; et al. 美国血液学会2025年关于老年新诊断急性髓系白血病治疗的指南。Blood Adv. 2025. [Google Scholar] [CrossRef]
err2026-03-13
err0
errOAAI
errMikkael A. Sekeres; Ryan Mattison; Andrew Artz; Maria R. Baer; Chong Chyn Chua; Roberta Demichelis-Gómez; Pamela C. Egan; Luke Fletcher; Charles Foucar; Jacqueline S. Garcia; Linda Gilberto; Andres Gómez de León; Jeffrey Lancet; Kah Poh Loh; Luca Malcovati; Bernard Marini; Uwe Platzbecker; Mohamed L. Sorror; Sara Tinsley-Vance; John Treitz
err分享
err收藏
Post-transplant MRD Monitoring by TP53 Duplex Sequencing with APR-246 + Azacitidine Maintenance Predicts Outcomes移植后微小残留病(MRD)通过TP53双测序结合APR-246 + 去氧氟尿苷维持治疗预测预后
err2025-11-27
err0
errOAAI
errDavid A. Sallman; Amy F. McLemore; Rami Komrokji; Hany Elmariah; Andrew T. Kuykendall; Nelli Bejanyan; Onyee Chan; Rawan Faramand; Joseph Pidala; Sean J. Yoder; Lia Perez; Taiga Nishihori; Eric Padron; Hugo Fernandez; Jeffrey E. Lancet; Asmita Mishra
err分享
err收藏
CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysisCPX-351与常规化疗的心脏毒性比较:高风险AML的III期试验事后分析
err2025-11-25
err0
errOAAI
errJoshua D. Mitchell; Michael Pfeiffer; John Boehmer; John Gorcsan; Shunsuke Eguchi; Yoshiyuki Orihara; Nalina Dronamraju; Sonja Dhani; Stefan Faderl; Tara L. Lin; Geoffrey L. Uy; Jeffrey E. Lancet; Jorge E. Cortes
err分享
err收藏
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia去甲基化药物与Venetoclax联合方案是老年(≥70岁)新诊断低危急性髓系白血病患者接受强化化疗的安全有效替代方案。
err2025-08-07
err0
PREAI
errSomedeb Ball; Akriti G. Jain; Najla Al Ali; Luis E. Aguirre; Jan Philipp Bewersdorf; Andrew Kent; Ameera Rose; Alexander Hayden; Alexa Siddon; Jill Lykon; Ellen Madarang; David M. Swoboda; Eric Padron; Kendra Sweet; David A. Sallman; Jeffrey Lancet; Hetty E. Carraway; Justin Watts; Amer Zeidan; Daniel A. Pollyea; Rami S. Komrokji
err分享
err收藏
Characterization of Indolent Chronic Myelomonocytic Leukemia Phenotypes and Dynamic Features of Disease Progression惰性慢性髓单核细胞白血病表型的特征描述及疾病进展的动态特征
err2025-03-29
err0
PREAI
errLuis E. Aguirre; Somedeb Ball; Akriti Jain; Najla Al Ali; David A. Sallman; Andrew Kuykendall; Kendra Sweet; Jeffrey E. Lancet; Eric Padron; Rami S. Komrokji
err分享
err收藏
Phase 1/1b Dose Escalation and Expansion of CPX-351 in Combination with Gemtuzumab Ozogamicin in Newly Diagnosed Acute Myeloid LeukemiaI期/II期剂量递增和扩展研究:CPX-351联合Gemtuzumab Ozogamicin治疗新诊断急性髓性白血病
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChan, Onyee; Sweet, Kendra L.; Talati, Chetasi; Zahra, Fatima Tuz; Nardelli, Lisa Ann; Lamba, Jatinder K.; Kim, Jongphil; Song, Jinming; Xie, Zhuoer; Yun, Seongseok; Kuykendall, Andrew T.; Padron, Eric; Walker, Alison R.; Komrokji, Rami S.; Lancet, Jeffrey E.; Sallman, David
err分享
err收藏
Clinical Relevance of Subgrouping in TP53 mutated Myelodysplastic Neoplasms: Insights from ICC and Who ClassificationsTP53突变骨髓增生异常性肿瘤中分型的临床相关性:来自ICC和WHO分类的见解
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errTashkandi, Hammad; Zhang, Xiaohui; Komrokji, Rami S.; Al Ali, Najla H.; Xie, Zhuoer; Walker, Alison R.; Padron, Eric; Lancet, Jeffrey E.; Sallman, David; Zhang, Ling
err分享
err收藏
Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Marker in Myelodysplastic Syndromes中性粒细胞与淋巴细胞比值是骨髓增生异常综合征的独立预后标志物
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errKomrokji, Rami S.; Komrokji, Zena; Al Ali, Najla H.; Xie, Zhuoer; Chan, Onyee; Kuykendall, Andrew T.; Jabbour, Joseph E.; Walker, Alison R.; Lancet, Jeffrey E.; Padron, Eric; Sallman, David
err分享
err收藏
IDH-1 Somatic Mutations Are More Commonly Observed Among Patients with Concomitant Myelodysplastic Syndromes (MDS) and Autoimmune Rheumatoid Diseases (AIRD)IDH-1体细胞突变在同时患有骨髓增生异常综合征(MDS)和自身免疫性风湿病(AIRD)的患者中更为常见。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errKomrokji, Rami S.; Al Ali, Najla H.; Xie, Zhuoer; Komrokji, Zena; Jabbour, Joseph E.; Chan, Onyee; Yun, Seongseok; Kuykendall, Andrew T.; Walker, Alison R.; Lancet, Jeffrey E.; Padron, Eric; Sallman, David
err分享
err收藏
Prospective Evaluation of the Impact of Measurable Residual Disease (MRD) By Error Corrected Next-Generation Sequencing (NGS) with CPX-351 in Acute Myeloid Leukemia (AML)CPX-351在急性髓系白血病(AML)中通过纠错型下一代测序(NGS)对可测量残留病灶(MRD)影响的展望性评估
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errSallman, David; Mclemore, Amy F.; Chan, Onyee; Kuykendall, Andrew T.; Padron, Eric; Xie, Zhuoer; Walker, Alison R.; Spencer, David H.; Komrokji, Rami S.; Lancet, Jeffrey E.; Jacoby, Meagan
err分享
err收藏
Real World Outcomes of Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia: A Single Center Experience急性髓系白血病口服阿扎胞苷维持治疗的真实世界结局:一项单中心经验
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errZahra, Fatima Tuz; Ong, Faustine; Walgenbach, Daniel; Chan, Onyee; Tobon, Katherine; Lancet, Jeffrey E.; Sallman, David; Komrokji, Rami S.; Kuykendall, Andrew T.; Padron, Eric; Walker, Alison R.; Xie, Zhuoer; Yun, Seongseok
err分享
err收藏
Disparities in AML Survival in the Targeted Therapy Era: Real World Evidence of Enhanced Equity of Outcomes for Patients in Medically Underserved Areas靶向治疗时代AML生存率的差异:医疗资源匮乏地区患者结局公平性提升的真实世界证据
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errZahra, Fatima Tuz; Ong, Faustine; Shahzad, Moazzam; Chan, Onyee; Al Ali, Najla H.; Lancet, Jeffrey E.; Walker, Alison R.; Sallman, David; Komrokji, Rami S.; Yun, Seongseok; Kuykendall, Andrew T.; Padron, Eric; Xie, Zhuoer
err分享
err收藏
Outcomes by best response with hypomethylating agent plus venetoclax in adults with previously untreated acute myeloid leukemia
err2024-09-07
err0
errOAAI
errJain, Akriti G.; Volpe, Virginia O.; Wang, Chen; Ball, Somedeb; Tobon, Katherine; Chan, Onyee; Padron, Eric; Kuykendall, Andrew; Lancet, Jeffrey E.; Komrokji, Rami; Sallman, David A.; Sweet, Kendra L.
err分享
err收藏
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment
err2024-06-20
err2
errOAAI
errGarciaz, Sylvain; Dumas, Pierre-Yves; Bertoli, Sarah; Sallman, David A.; Decroocq, Justine; Belhabri, Amine; Orvain, Corentin; Requena, Gaspar Aspas; Simand, Celestine; Laribi, Kamel; Carre, Martin; Santagostino, Alberto; Himberlin, Chantal; Peterlin, Pierre; Bonnet, Sarah; Chan, Onyee; Lancet, Jeffrey; Komrokji, Rami; Vergez, Francois; Chapuis, Nicolas; Raskovalova, Tatiana; Plesa, Adriana; Lhoumeau, Anne-Catherine; Mineur, Ariane; Hospital, Marie Anne; Pigneux, Arnaud; Vey, Norbert; Recher, Christian
err分享
err收藏
Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML慢性期CML患者达沙替尼胸腔积液的发生率以及将治疗转换为不同TKI的效果
err2024-04-18
err3
errOAAI
errJain, Akriti G.; Gesiotto, Quinto; Ball, Somedeb; Nodzon, Lisa; Rodriguez, Amanda; Chan, Onyee; Padron, Eric; Kuykendall, Andrew; Komrokji, Rami; Sallman, David A.; Lancet, Jeffrey E.; Pinilla-Ibarz, Javier; Sweet, Kendra
err分享
err收藏
Mutations highly speci fi c for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML
err2024-02-28
err5
errOAAI
errChan, Onyee; Al Ali, Najla; Tashkandi, Hammad; Ellis, Austin; Ball, Somedeb; Grenet, Justin; Hana, Caroline; Deutsch, Yehuda; Zhang, Ling; Hussaini, Mohammad; Song, Jinming; Yun, Seongseok; Talati, Chetasi; Kuykendall, Andrew; Padron, Eric; Walker, Alison; Roboz, Gail; Desai, Pinkal; Sallman, David; Sweet, Kendra; Komrokji, Rami; Lancet, Jeffrey
err分享
err收藏
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia低风险骨髓增生异常综合征进展的模式: 预测进展为高风险骨髓增生异常综合征和急性髓系白血病的因素
err2024-02-01
err3
errOAAI
errJain, Akriti G.; Ball, Somedeb; Aguirre, Luis; Al Ali, Najla; Kaldas, David; Tinsley-Vance, Sara; Kuykendall, Andrew; Chan, Onyee; Sweet, Kendra; Lancet, Jeffrey E.; Padron, Eric; Sallman, David A.; Komrokji, Rami
err分享
err收藏
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
err2023-12-22
err1
errOAAI
errDukes, Christopher W.; Potez, Marine; Lancet, Jeffrey; Kuter, Barbara J.; Whiting, Junmin; Mo, Qianxing; Leav, Brett; Wang, Haixing; Vanas, Julie S.; Cubitt, Christopher L.; Isaacs-Soriano, Kimberly; Kennedy, Kayoko; Rathwell, Julie; Cobo, Julian Diaz; O'Nan, Wesley; Sirak, Bradley; Dong, Ning; Tan, Elaine; Hwu, Patrick; Giuliano, Anna R.; Pilon-Thomas, Shari
err分享
err收藏
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities
err2023-11-30
err2
PREAI
errHorvat, Nathan P.; Abdallah, Enas F.; Xie, Zhuoer; Al Ali, Najla; Yun, Seongseok; Walker, Alison; Padron, Eric; Sallman, David; Chan, Onyee; Lancet, Jeffrey; Komrokji, Rami; Kuykendall, Andrew T.
err分享
err收藏